|
SLC25A32 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67819980134709E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.80870898655894E-12 |
| Normal-vs-Stage2 |
2.19040000004611E-06 |
| Normal-vs-Stage3 |
2.507600E-01 |
| Normal-vs-Stage4 |
7.039000E-01 |
| Stage1-vs-Stage2 |
3.239600E-01 |
| Stage1-vs-Stage3 |
9.218000E-04 |
| Stage1-vs-Stage4 |
3.771800E-02 |
| Stage2-vs-Stage3 |
1.876160E-02 |
| Stage2-vs-Stage4 |
8.961700E-02 |
| Stage3-vs-Stage4 |
7.735200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17640008845399E-10 |
| Normal-vs-AfricanAmerican |
1.88350002261473E-09 |
| Normal-vs-Asian |
4.093600E-01 |
| Caucasian-vs-AfricanAmerican |
7.135600E-01 |
| Caucasian-vs-Asian |
2.052000E-01 |
| AfricanAmerican-vs-Asian |
1.675370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07629460899261E-11 |
| Normal-vs-Female |
1.440900E-04 |
| Male-vs-Female |
8.737300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55934999999108E-05 |
| Normal-vs-Extreme_Weight |
2.10860218174957E-11 |
| Normal-vs-Obese |
3.95930000000044E-05 |
| Normal-vs-Extreme_Obese |
1.00499999988735E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.803380E-01 |
| Normal_Weight-vs-Obese |
6.798800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.729240E-01 |
| Extreme_Weight-vs-Obese |
5.842200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.773600E-01 |
| Obese-vs-Extreme_Obese |
2.863900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.289200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.02220043330226E-10 |
| Normal-vs-Age(61-80Yrs) |
6.4431793234121E-12 |
| Normal-vs-Age(81-100Yrs) |
1.10969999966848E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.892410E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.783500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.116500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.721980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.310000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.116600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.52249999999066E-07 |
| Normal-VS-KIRP CIMP |
2.297700E-02 |
| Normal-VS-Unclassified PRCC |
3.03570000026454E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.159400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.416600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.636300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.03379999508257E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
6.391400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.816200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.30630001155185E-09 |
| Normal-vs-N1 |
5.326600E-01 |
| Normal-vs-N2 |
6.934800E-01 |
| N0-vs-N1 |
5.419800E-04 |
| N0-vs-N2 |
4.113000E-01 |
| N1-vs-N2 |
5.136200E-01 |
|
|
